Vendor, Pittsburgh, PA
Washburn Therapeutics, Inc.
UEI D6FWWNAJCMJ7, CAGE 4TSV1
1 award and -$241,808 obligated between February 12, 2024 and February 12, 2024, 100% under full and open competition, against 41.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | -$241,808 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| W5170124C0009Definitive Contract, February 12, 2024, Full and Open Competition After Exclusion of Sources, 41 offers | W27P USA Acq SPT CTRDepartment of the Army | "washburn Therapeutics, Inc." SBIR PH INAICS 541715, PSC AC12 | -$241,808 |
- Places of performance
- Pennsylvania
- Product and service codes
- AC12 National Defense R&D Services; Department Of Defense - Military; Applied Research
- Transactions
- 1 across 1 awards